Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease.
Br J Haematol. 2015 Nov;171(3):424-7. doi: 10.1111/bjh.13395. Epub 2015 Apr 7.
Br J Haematol. 2015.
PMID: 25851809
Free article.
No abstract available.
Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist.
Zivkovic M, Pols-van Veen E, van der Vegte V, Sebastian SAE, de Moor AS, Korporaal SJA, Schutgens REG, Urbanus RT; Thrombocytopathy in the Netherlands (TiN) study group; SYMPHONY consortium.
Zivkovic M, et al.
Res Pract Thromb Haemost. 2024 Oct 3;8(7):102582. doi: 10.1016/j.rpth.2024.102582. eCollection 2024 Oct.
Res Pract Thromb Haemost. 2024.
PMID: 39512585
Free PMC article.
Item in Clipboard
The use of rituximab therapy in patients with acquired factor V inhibitors.
Navarrete MA, van der Meer FJ, Damiani G, Diaz A, Eikenboom J.
Navarrete MA, et al.
Am J Hematol. 2012 Aug;87(8):826-7. doi: 10.1002/ajh.23241. Epub 2012 May 28.
Am J Hematol. 2012.
PMID: 22641484
Free article.
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.